GSK CEO Follows Oncology Rivals’ Playbook in Search of Growth
GSK Plc is planning five simultaneous late-stage trials for a cancer drug it hopes will be a blockbuster, as new…
Tag: GSK
GSK Secures High Blood Pressure Drug in $950 Million Deal
GSK Plc agreed to buy 35Pharma Inc., a biotech with an early-stage high blood pressure drug, as the UK pharmaceutical…
GSK plc (GSK) Q4 Results Topped Forecasts as Specialty Medicines Jump 17%
GSK plc (NYSE:GSK) ranks among the best undervalued European stocks to buy now. On February 4, GSK plc (NYSE:GSK) announced…
GSK eyes sharper, faster drug development as new CEO signals growth plan
By Bhanvi Satija and Pushkala Aripaka LONDON, Feb 4 (Reuters) – GSK’s new CEO Luke Miels said on Wednesday that…
GSK Profit Lifted By HIV, Asthma Drugs Giving Boost to New CEO
GSK Plc reported better-than-expected profit in the fourth quarter, buoyed by its HIV and asthma medicines. www.bloomberg.com #GSK #Profit #Lifted…
Pfizer to Exit ViiV Healthcare as GSK and Shionogi Reshape Ownership
Pfizer Inc. (NYSE:PFE) is included among Dividend Contenders List: Top 20 Stocks. Pfizer to Exit ViiV Healthcare as GSK and…
Stock Movers: LVMH, Ferritti, GSK (Podcast)
Source: Bloomberg, 4:44 www.bloomberg.com #Stock #Movers #LVMH #Ferritti #GSK #Podcast
GSK announces $2.2 billion deal, targeting once-per-three-month food allergy drug
The growing scourge of food allergies drove U.K. heavyweight GSK to announce a $2.2 billion deal on Tuesday. www.marketwatch.com #GSK…
Jefferies Reaffirms a Buy Rating on GSK plc (GSK) – Here’s Why
GSK plc (NYSE:GSK) is one of the best performing pharma stocks in 2025. Jefferies reaffirmed a Buy rating on GSK…
HSBC Sees Pharma Poised to Outperform in 2026, Lifts GSK Target
GSK plc (NYSE:GSK) is included among the 15 Global Dividend Stocks to Diversify Your Portfolio. HSBC Sees Pharma Poised to…